BioMarin (BMRN) Decline Relates to High Expectations; Deutsche Bank Maintains Hold
Tweet Send to a Friend
Deutsche Bank today maintained an Hold rating on BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) with a price target of $75.00. Shares ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
